Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jenny Beygo"'
Autor:
Giovanni Della Cioppa, Astrid Borkowski, Timo Vesikari, Frank von Sonnenburg, Aino Forstén, Jenny Beygo, Nicola Groth, Karl-Heinz Herbinger, Mariaviviana Bennati
Publikováno v:
Vaccine. 30:1388-1396
Background The potential consequences of an avian influenza pandemic warrants the development of safe, highly immunogenic pre-pandemic A/H5N1 vaccines with cross-clade protection. In this randomized, controlled study we compared the immunogenicity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1a2ecabdc7eff3ac202d85f3476817
https://doi.org/10.1016/j.vaccine.2011.12.009
https://doi.org/10.1016/j.vaccine.2011.12.009
Publikováno v:
Clinical and vaccine immunology : CVI. 19(12)
Preparedness against an A/H5N1 influenza pandemic requires well-tolerated, effective vaccines which provide both vaccine strain-specific and heterologous, cross-clade protection. This study was conducted to assess the immunogenicity and safety profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4cabdeb64ae6bf02387b1ec4c45ddd
https://pubmed.ncbi.nlm.nih.gov/23081815
https://pubmed.ncbi.nlm.nih.gov/23081815
Autor:
M. Lourdes Guerrero, Stan L. Block, Guillermo M. Ruiz-Palacios, Jenny Beygo, Sandra J Holmes, Victor Sales
Publikováno v:
The Pediatric infectious disease journal. 31(7)
The successful vaccination of children 6 to 36 months of age against 2009 A/H1N1 influenza was essential to help reduce the burden of pandemic disease in both the pediatric and adult populations.We compared the immunogenicity and safety of 4 alternat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c06e241f2da94c57d488faef20784a26
https://pubmed.ncbi.nlm.nih.gov/22481427
https://pubmed.ncbi.nlm.nih.gov/22481427